Synthesis of isoselenazolo- or isothiazolo[4,3-e][1,4]diazepines

DOI: 10.1248/cpb.36.2902

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2902 - 2908 (1988)

Update date:2022-08-02

Topics:

Authors:

Ueda Ueda

Kato Kato

Sakakibara

Murata Murata

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.36.2902

Full text of DOI:10.1248/cpb.36.2902

NII-Electronic Library Service

Products guided by the article

Product name:4-(2-Bromo-butyrylamino)-isothiazole-3-carboxylic acid phenylamide

Cas No:119451-98-8

R&D Labs maybe for 119451-98-8

Hubei Lingsheng Pharmaceuticals Co., Ltd.

Contact:+86-0710-3538058

Address:Xiangyang City Xiangcheng Economic Development Zone, Hubei Province
Shandong Jincheng Zhonghua Bio-pharmaceutical Co.,Ltd

Contact:+86-533-5415882

Address:Zichuan Economic Development Zone,Zibo City,Shandong Province,China
BAODING SINO-CHEM INDUSTRY CO.,LTD

Contact:0312-5956088

Address:NO.8 FUXING ROAD,CHINA
Antaeus Bio-technology Co., LTD(expird)

Contact:021-31252569

Address:shanghai pudong
Hefei EnliPharma Tecnology Co.,Ltd

Contact:0086-551-66399836

Address:Qing Cheng ShuiXiang Building 805, Mengcheng North Road , ShuangFeng Economic Development Zone Anhui HeFei

Relevant to this article

Methyl Scanning and Revised Binding Mode of 2-Pralidoxime, an Antidote for Nerve Agent Poisoning

Doi:10.1021/acsmedchemlett.9b00586
(2020)
An efficient cascade synthesis of various 2H-1,4-benzoxazin-3-(4H)-ones from o-halophenols and 2-halo-amides catalyzed by CuI

Doi:10.1039/b906210f
(2009)
Columnar mesophases controlled by counterions in potassium complexes of dibenzo[18]crown-6 derivatives

Doi:10.1002/chem.200901173
(2009)
Detection of in vivo matrix metalloproteinase activity using microdialysis sampling and liquid chromatography/mass spectrometry

Doi:10.1021/ac901703g
(2009)
Efficient synthesis of spiro[diindenopyridine-indoline]triones Catalyzed by PEG-OSO₃H-H₂O and [NMP]H₂PO₄

Doi:10.1080/00397911.2014.906616
(2015)
Discovery of potent, selective and orally bioavailable imidazo[1,5-a] pyrazine derived ACK1 inhibitors

Doi:10.1016/j.bmcl.2012.12.042
(2013)

Article Doi